Search

Memorial Sloan Kettering Cancer Center (MSK) today announced that the New York State Department of Health has issued approval for a new molecular assay, Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS).  MSK-ACCESS was developed within the Marie-Josee and Henry R. Kravis Center for Molecular Oncology (CMO) and the test has been clinically validated and implemented by members of MSK’s Molecular Diagnostics Service.

… Tuesday, June 11, 2019 Memorial Sloan Kettering Cancer Center (MSK) announced that the New York State Department of Health has issued an approval for a new molecular assay called Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS). MSK-ACCESS was developed within the Marie-Josée and

Memorial Sloan Kettering Cancer Center (MSK) today announced that Rémy Evard has joined as its new Chief Digital Officer and Head of Technology.

… Thursday, January 13, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced that Rémy Evard has joined as its new Chief Digital Officer and Head of Technology. In this role, Evard will be responsible for the overall design and execution of the organization’s digital strategy. Evard joins

Sloan Kettering Institute investigators have learned how Hedgehog proteins, which are important in both development and cancer, are assembled.

… Thursday, June 10, 2021 Hedgehog proteins are some of the most important molecules in biology. These proteins help regulate cell growth, specialization, and patterning in the development of embryos by acting as messengers between cells. In addition to playing a key role in how proper tissues are formed

As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.

… Friday, October 1, 2010 Summary As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials. As part of a commitment

An MSK program helps lung cancer survivors stay healthy following successful treatment for their disease.

… Tuesday, December 10, 2024 Summary With more people surviving longer after lung cancer , close management of those who have had successful treatment is more important than ever. MSK’s Lung Cancer Survivorship Program provides regular screening for recurrent cancers or new tumors, as well as guidance

Un programa de MSK ayuda a los sobrevivientes de cáncer pulmonar a mantenerse saludables después de un tratamiento exitoso contra su enfermedad.

… Tuesday, December 10, 2024 Resumen Debido a que más personas sobreviven por más tiempo después de un cáncer pulmonar , el seguimiento cercano de quienes han recibido un tratamiento exitoso es más importante que nunca. El Programa de Sobrevivencia de Cáncer Pulmonar de MSK ofrece exámenes regulares para

Learn how a blood test could someday provide a way to detect cancers at an early stage.

… Friday, October 13, 2023 A blood test that could detect multiple cancers at their earliest stages has long been a dream of the medical community. Now results from a pilot study, published in The Lancet , suggest that a single blood test might identify the presence of more than 50 cancer types . The experimental

In her role as Vice Chair Health Equity, Department of Surgery, Carol Brown, MD, took part in The Atlantic’s virtual event, People v. Cancer: Equity in Care.

… Monday, November 2, 2020 In her role as Vice Chair Health Equity, Department of Surgery, Carol Brown, MD , took part in The Atlantic’s virtual event, People v. Cancer: Equity in Care . The online session explored the health equity challenges facing patients, providers, and institutions and what is being

The majority of young women at an increased risk of breast cancer due to chest radiation treatment for childhood cancer are not following breast cancer screening recommendations, according to a recently released, detailed assessment appearing in the January 28, 2009, issue of the Journal of the American Medical Association.

… Tuesday, January 27, 2009 The majority of young women at an increased risk of breast cancer due to chest radiation treatment for childhood cancer are not following breast cancer screening recommendations, according to a recently released, detailed assessment appearing in the January 28, 2009, issue of

On April 27 and 28 at Mohonk Mountain House in New Paltz, New York, Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) held its fifth biennial retreat for members of the school’s community.

… Wednesday, May 16, 2018 On April 27 and 28 at Mohonk Mountain House in New Paltz, New York, Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) held its fifth biennial retreat for members of the school’s community. Participants included students, faculty members, and staff. The keynote